MedPath
HSA Approval

STONA COLD CAPLETS

SIN07778P

STONA COLD CAPLETS

STONA COLD CAPLETS

July 15, 1994

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO LTD

Active Ingredients

ACETAMINOPHEN

150 mg

Acetaminophen

CAFFEINE (ANHYDROUS)

25 mg

Caffeine

GUAIFENESIN

41.67 mg

Guaifenesin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STONA COLD CAPLETS - HSA Approval | MedPath